Jefferies Financial Group’s Aclaris Therapeutics ACRS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $15.6K | Sell |
11,000
-29,200
| -73% | -$41.5K | ﹤0.01% | 958 |
|
|
2025
Q1 | $61.5K | Sell |
40,200
-500
| -1% | -$765 | ﹤0.01% | 1261 |
|
|
2024
Q4 | $101K | Buy |
40,700
+29,200
| +254% | +$72.4K | ﹤0.01% | 1148 |
|
|
2024
Q3 | $13.2K | Hold |
11,500
| – | – | ﹤0.01% | 1084 |
|
|
2024
Q2 | $12.7K | Hold |
11,500
| – | – | ﹤0.01% | 1071 |
|
|
2024
Q1 | $14.3K | Hold |
11,500
| – | – | ﹤0.01% | 1194 |
|
|
2023
Q4 | $12.1K | Sell |
11,500
-25,051
| -69% | -$26.3K | ﹤0.01% | 1194 |
|
|
2023
Q3 | $250K | Buy |
36,551
+10,000
| +38% | +$68.5K | ﹤0.01% | 878 |
|
|
2023
Q2 | $275K | Sell |
26,551
-390,000
| -94% | -$4.04M | ﹤0.01% | 932 |
|
|
2023
Q1 | $3.37M | Buy |
+416,551
| New | +$3.37M | 0.03% | 260 |
|